Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
15 drugs in development
By Therapeutic Area
top 6
R&D Momentum
95/100
Pipeline Velocity
73/100
Trial Completion Rate
87/100
Pipeline Concentration
21/100
Pipeline Freshness
21/100
Strategic Signals
Activity
Last 14 days
Monitoring and Optimization of Cerebral Perfusion Pressure in Post-cardiac Arrest Patients: a Pilot Study
Carotid Ultrasound Under Pulsed-wave Doppler Mode to Check the Pulse in Cardiopulmonary Arrest Patients.
Effects of Self-controlled Practice on Motor Learning and Motivation in People With Parkinson's Disease
Unraveling Visuomotor Control in Parkinson Disease With and Without Freezing of Gait
Pilot Study of Single-Port Robot-Assisted Surgery Using Da Vinci SP Surgical System for Patients With Complex Cholelithiasis and Choledocholithiasis
Tarlatamab for Patients With Previously Treated Advanced Extrapulmonary Small Cell Carcinoma and Neuroendocrine Carcinoma
Cohort Studies on Metabolic Syndrome and Prediabetes
Augmented Benefits of Different Exercise Types to Enhance Skill Learning in People With Parkinson's Disease
Effectiveness of a Wearable Device and AI-Supported Diet and Exercise Intervention in Obese Adults-a Quasi-experimental Design Study
A Study on the Effects of Forest Therapy on Sarcopenia
Cohort Study of Patients With Type 2 Diabetes
A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)